Completed Projects

HOME > R&D Pipeline > Current status > Completed Projects

KDDF-201110-08 Development of GPR119 agonist for treating diabetes together with body weight loss effect(Metabolic Disorders, Chemical) [01.04.2013]

PRINT

Development and Market Objectives

Unmet Medical Need & Target Patients

Status

Intellectual Property

Competitive Advantages

Indication

Diabetes and obesity

Research Period

March, 2012 ~ October, 2012

Company

Hanmi Pharmaceutical Co., Ltd.

Developmental Stage

Lead Optimization

Additional Information

Contact Information

Contact
Address Company Name: Hanmi Pharmaceutical Co., Ltd.
WebSite Homepage: http:// Contact Person:
E-mail: Contact:

Related Projects

Related Project
list
Update to 2013 © KOREA DRUG DEVELOPMENT FUND. ALL RIGHTS RESERVED. QR Code